IRIS
LUGHEZZANI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.953
EU - Europa 1.794
AS - Asia 415
AF - Africa 335
SA - Sud America 20
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 12
Totale 10.543
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.888
FI - Finlandia 479
IE - Irlanda 379
NG - Nigeria 323
CN - Cina 240
DE - Germania 206
IT - Italia 193
FR - Francia 182
NL - Olanda 96
GB - Regno Unito 81
SE - Svezia 74
TR - Turchia 67
CA - Canada 63
IN - India 30
IL - Israele 23
RU - Federazione Russa 22
CL - Cile 17
BE - Belgio 16
AU - Australia 14
MK - Macedonia 13
RO - Romania 13
A2 - ???statistics.table.value.countryCode.A2??? 9
HK - Hong Kong 9
EG - Egitto 8
JP - Giappone 8
PH - Filippine 8
CH - Svizzera 6
IR - Iran 6
ES - Italia 5
PL - Polonia 5
DK - Danimarca 4
SG - Singapore 4
TW - Taiwan 4
UA - Ucraina 4
AT - Austria 3
BD - Bangladesh 3
BR - Brasile 3
EU - Europa 3
MD - Moldavia 3
NO - Norvegia 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
DZ - Algeria 2
GR - Grecia 2
PA - Panama 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
VN - Vietnam 2
GE - Georgia 1
HU - Ungheria 1
LB - Libano 1
MU - Mauritius 1
MY - Malesia 1
TH - Thailandia 1
UG - Uganda 1
Totale 10.543
Salva come PNG Salva come JPEG
Città #
Wilmington 1.815
Chandler 1.306
San Mateo 715
Ann Arbor 512
Helsinki 479
Dublin 378
Leawood 329
Lawrence 326
Princeton 326
Benin City 323
Shanghai 227
Boardman 190
Ashburn 188
Fairfield 186
Woodbridge 186
Paris 179
New York 148
Milan 109
Amsterdam 86
London 72
Kocaeli 66
Toronto 56
San Diego 41
Norwalk 35
Seattle 31
Los Angeles 29
Pune 25
Falls Church 18
Phoenix 17
Brussels 15
Des Moines 14
Falkenstein 14
Redmond 14
Monmouth Junction 13
Frankfurt am Main 12
Moscow 10
Andover 9
Abbiategrasso 8
Santa Clara 8
Skopje 8
Terracina 8
Clearwater 6
Las Vegas 6
Redwood City 6
Siracusa 6
Bitola 5
Cairo 5
Cambridge 5
Guangzhou 5
Henderson 5
Santiago 5
Meppel 4
Novokuznetsk 4
Samarate 4
Alexandria 3
Augusta 3
Berlin 3
Büdelsdorf 3
Chisinau 3
Gunzenhausen 3
Jacksonville 3
Logan 3
Melbourne 3
Olongapo City 3
Saint Louis 3
Saint Paul 3
Singapore 3
St Petersburg 3
Tappahannock 3
Umeå 3
Barcelona 2
Central 2
Chicago 2
Den Haag 2
Dhaka 2
Eden Prairie 2
Esslingen am Neckar 2
Gdansk 2
Hanoi 2
Hialeah 2
Hsinchu 2
Kemerovo 2
La Canada Flintridge 2
Las Pinas 2
Mabalacat 2
Sale Marasino 2
Schwenksville 2
Sherbrooke 2
Sougueur 2
Taipei 2
Toba Tek Singh 2
Tokyo 2
Venegono Superiore 2
Aarau 1
Aarhus 1
Adelaide 1
Alcamo 1
Ardabil 1
Athens 1
Bangkok 1
Totale 8.698
Salva come PNG Salva come JPEG
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 109
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer. 108
137 PHI (Prostate Health Index) and %p2PSA for prediction of prostate cancer in men younger than 60 years of age. A nested-case control study from PROpsa Multicentric European Study (PROMEtheuS project) 90
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) project 73
arallel comparison of 68Ga-Prostate Specific Membrane Antigen PET-CT and PRIMUS in primary prostate cancer diagnosis 64
Ga-68-PSMA Positron Emission Tomography/Computerized Tomography for Primary Diagnosis of Prostate Cancer in Men with Contraindications to or Negative Multiparametric Magnetic Resonance Imaging: A Prospective Observational Study 61
"En Bloc" Resection of Nonmuscle Invasive Bladder Cancer: A Prospective Single-center Study 60
Prospective evaluation of Ga-68-PSMA PET/CT in primary prostate cancer diagnosis - final results of a dedicated trial 58
Re: Comparative Analysis of Transperineal Template Saturation Prostate Biopsy Versus Magnetic Resonance Imaging Targeted Biopsy with Magnetic Resonance Imaging-Ultrasound Fusion Guidance 57
Ga-68-PSMA PET/CT for primary diagnosis of prostate cancer in men with contraindications to or negative mpMRI 57
Two-dimensional neovascular complexity is significantly higher in nontumor prostate tissue than in low-risk prostate cancer 56
68GA-PSMA PET/CT FOR PRIMARY DIAGNOSIS OF PROSTATE CANCER IN MEN WITH CONTRAINDICATIONS TO OR NEGATIVE MRI: A PROSPECTIVE OBSERVATIONAL STUDY 56
Comparison of PHI (Prostate Health Index) and PCA3 assay in the prediction of prostate biopsy (PBx) outcome in patients who have undergone initial and repeated prostatic biopsies 54
[Focal therapy and prostate cancer]. 54
-2PROPSA, %-2PROPSA AND PHI (PROSTATE HEALTH INDEX) CORRELATE WITH CANCER AGGRESSIVENESS IN PATIENTS WHO UNDERWENT RADICAL PROSTATECTOMY 54
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project 54
63 Preoperative predictors of positive surgical margins in a contemporary cohort of patients treated with bilateral nerve sparing robot assisted laparoscopic radical prostatectomy 53
HOW TO SIMPLIFY PATIENT POSITIONING AND PORT PLACEMENT DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY (RALP) 51
MIDDLE TERM FOLLOW-UP RESULTS OF MAGNETIC RESONANCE IMAGING EVALUATION AFTER FOCAL THERAPY FOR PROSTATE CANCER 51
855 Definition of the Limit of Detection (LoD) for serum isoform [−2]proPSA in patients with recurrent prostate cancer after radical prostatectomy: An analytic study 51
P2PSA AND DERIVATIVES (% P2PSA AND PHI) ACCURATELY PREDICT PROSTATE CANCER IN OBESE MEN FROM A MULTICENTER PROSPECTIVE EUROPEAN STUDY 51
[-2]PROPSA (P2PSA) AND ITS DERIVATIVES %P2PSA AND PHI (PROSTATE HEALTH INDEX) IN A REAL CLINICAL SETTING OF CONTEMPORARY MEN UNDERGOING PROSTATE BIOPSY FOR SUSPECTED PROSTATE CANCER. A SINGLE HIGH-VOLUME CENTER EXPERIENCE 51
The Management of Small Renal Masses: Renal Anatomy and Physiology 51
MAGNETIC RESONANCE IMAGING ALONE SHOULD NOT BE CONSIDERED AS A STAND-ALONE TEST FOR DISEASE RECLASSIFICATION OF MEN IN ACTIVE SURVEILLANCE 50
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolò Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. 50
[-2]PROPSA FOR PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: PRELIMINARY RESULTS FROM AN OBSERVATIONAL COHORT STUDY 50
A Population-based Analysis of the Rate of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the United States 50
How Should We Report Incontinence After Radical Prostatectomy? 49
INTRAFASCIAL TECHNIQUE OFFERS IMPROVED FUNCTIONAL OUTCOMES IN PATIENTS TREATED WITH BILATERAL NERVE SPARING ROBOTIC RADICAL PROSTATECTOMY 49
Complications and Quality of Life After Template-assisted Transperineal Prostate Biopsy in Patients Eligible for Focal Therapy 49
IMPACT OF MINIMALLY INVASIVE APPROACH ON THE PROBABILITY OF EARLY COMPLETE FUNCTIONAL RECOVERY AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 49
An observational study of the use of beclomethasone dipropionate suppositories in the treatment of lower urinary tract inflammation in men 49
A Population-based Assessment of Perioperative Mortality After Nephroureterectomy for Upper-tract Urothelial Carcinoma 49
A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma REPLY 49
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY: SINGLE INSTITUTION 16-YEAR EXPERIENCE 48
Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms? 48
Pyeloplasty using the novel da Vinci single site robotic platform for the surgical treatment of uretero-pelvic junction obstruction: The technique 48
Urethral Lift for Benign Prostatic Hyperplasia: A Comprehensive Review of the Literature 48
Robot-assisted laparoscopic partial nephrectomy with Alf–X Robot on pig model 48
XPERTBLADDER MONITOR TEST FOR FAILURE DEFINITION OF PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC) WITH NEGATIVE CITOLOGY 48
SENSITIVITY OF [-2]PROPSA AS AN ULTRASENSITIVE PSA SURROGATE FOR THE PREDICTION OF EARLY BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY: AN OBSERVATIONAL COHORT STUDY 47
Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions 47
ACTIVE SURVEILLANCE FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC): RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 47
54 Safety and efficacy of robot-assisted laparoscopic partial nephrectomy during the learning curve in a high volume urological center 47
Accuracy of p2PSA and derivatives (%p2PSA and PHI) in predicting prostate cancer in obese men from a multicenter European study 47
254 Margin, Ischemia, and Complications (MIC) System to report perioperative outcomes of robot-assisted partial nephrectomy: A European Multicenter Observational Study (EMOS project) 47
Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review 47
THE EFFECT OF PREOPERATIVE CANCER AGGRESSIVENESS ON LEARNING CURVE AMONG HIGH VOLUME SURGEONS PERFORMING RADICAL RETROPUBIC PROSTATECTOMY. 46
Pathological Outcomes for Patients Who Failed To Remain Under Active Surveillance for Low-risk Non-muscle-invasive Bladder Cancer: Update and Results from the Bladder Cancer Italian Active Surveillance Project 46
Is Robotic Surgery Unnecessary for Adrenalectomy? Weighting the Pros and Cons of the Robotic Approach 45
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) 45
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma 45
A POPULATION-BASED ANALYSIS OF PERIOPERATIVE COMPLICATIONS AND MORTALITY ASSOCIATED WITH CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA 45
Margin, Ischemia, and Complications System to Report Perioperative Outcomes of Robotic Partial Nephrectomy: A European Multicenter Observational Study (EMOS Project) REPLY 45
Reply from Authors re: Monique J. Roobol. Prostate Cancer Biomarkers to Improve Risk Stratification: Is Our Knowledge of Prostate Cancer Sufficient to Spare Prostate Biopsies Safely? Eur Urol 2011;60:223-5 and re: Carvell T. Nguyen, Michael W. Kattan. How to Tell If a New Marker Improves Prediction 44
UROLOGIST LEARNING CURVE HAS AN IMPACT ON INCREASING PROBABILITY OF CLINICALLY SIGNIFICANT CANCER DETECTION RATE AT MPMRI-TRUS FUSION TARGET BIOPSY: A PROSPECTIVE STUDY IN A SINGLE HIGH VOLUME INSTITUTION 44
Primary diagnosis of prostate cancer: potential role of Ga-68-Prostate Specific Membrane Antigen PET/CT 44
POPULATION-BASED COMPARISON OF CANCER SPECIFIC MORTALITY AFTER LOCAL TUMOR ABLATION OR NON-ACTIVE TREATMENT FOR T1A KIDNEY CANCER: A COMPETING RISK ANALYSIS 44
Reply to Marc A. Bjurlin, Lee C. Zhao, and Michael D. Stifelman's Letter to the Editor Re: Nicolo Maria Buffi, Giovanni Lughezzani, Rodolfo Hurle, et al. Robot-assisted Surgery for Benign Ureteral Strictures: Experience and Outcomes from Four Tertiary Care Institutions. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.022 44
ABSENCE OF LEARNING CURVE IMPACT MAY LET MRI-TRUS FUSION GUIDED BIOPSY UP FOR EARLY DIAGNOSIS OF PROSTATE CANCER 43
Predicting Cancer-specific Mortality After Radical Prostatectomy: Still a Long Way To Go 43
Predictive factors for progression of patients with carcinoma in situ of the bladder at long-term follow-up: pure versus non-pure CIS 43
Active surveillance for low-risk Non-Muscle Invasive Bladder Cancer (NMIBC): mid-term results from a Bladder cancer Italian Active Surveillance (BIAS) project. 43
A Population-based Comparison of Cancer-control Rates Between Radical and Partial Nephrectomy for T1A Renal Cell Carcinoma 43
LIQUID BIOPSY BY PROSTATE-DERIVED TUMOR CELLS ENRICHED FROM SEMINAL FLUID (SF): THE SEMEN PROSTATE CANCER TUMOR ELEMENTS (SPECTRE) PROJECT. 43
Clinical use of [-2]proPSA (p2PSA) and its derivatives (%p2PSA and Prostate Health Index) for the detection of prostate cancer: a review of the literature. 43
NEW CONCEPTION FOR FLEXOR VUE DEFLECTING ENDOSCOPIC SYSTEM USE, IN ORDER TO IMPROVE STONE FREE RATE (SFR) AFTER RIRS: PRELIMINARY RESULTS FROM A SINGLE CENTRE STAGE 2A STUDY 43
Surgery illustrated--Surgical Atlas. Robotic radical cystectomy in the male. 42
Re: Guazzoni et al.: Oncologic Results of Laparoscopic Renal Cryoablation for Clinical T1a Tumors: 8 Years of Experience in a Single Institution (Urology 2010; 76: 624-629) Reply 42
p2PSA for predicting biochemical recurrence of prostate cancer earlier than total prostate-specific antigen after radical prostatectomy: an observational prospective cohort study 42
Functional outcomes after robot-assisted radical prostatectomy in young patients (≤ 55 yrs) with prostate cancer: Is surgery perfect in the best candidates? 42
INTRAFASCIAL BILATERAL NERVE SPARING RADICAL PROSTATECTOMY: DOES THE ROBOTIC-ASSISTED APPROACH PREDISPOSE TO HIGHER RISK OF POSITIVE SURGICAL MARGINS? IMPORTANCE OF PATIENT SELECTION 42
A Proposal for Reclassification of the Fuhrman Grading System in Patients with Clear Cell Renal Cell Carcinoma 42
A Contemporary Population-Based Assessment of the Rate of Lymph Node Dissection for Penile Carcinoma 42
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidence 42
Long-term oncologic outcomes of laparoscopic renal cryoablation as primary treatment for small renal masses 41
COMPARISON BETWEEN PCA3 AND PHI SPECIFICTY AND SENSITIVITY IN PREDICTING THE PRESENCE OF CANCER AT INITIAL OR REPEAT BIOPSY 41
The relationship between continence and perineal body tone before and after radical prostatectomy: A pilot study 41
SHOULD WE CONTINUE TO BIOPSY MEN WITH PI-RADS III AFTER PREVIOUS NEGATIVE BIOPSY? 41
Targeted 11C–choline PET-CT/TRUS software fusion-guided prostate biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy 41
Isoform [-2]proPSA (p2PSA) and its derivates, %p2PSA and PHI values differ between BPH, ASAP, HG-PIN and PCa in a set of contemporary men undergoing prostate biopsy 41
EXTERNAL VALIDATION OF A PROSTATE HEALTH INDEX ( PHI) BASED NOMOGRAM FOR PREDICTING PROSTATE CANCER AT EXTENDED BIOPSY IN A EUROPEAN MULTICENTER POPULATION 41
Preoperative prostate-specific antigen isoform p2PSA and its derivatives, %p2PSA and prostate health index, predict pathologic outcomes in patients undergoing radical prostatectomy for prostate cancer 41
Clinical performance of prostate health index in men with tPSA>10ng/ml: Results from a multicentric European study. 41
Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination 40
UP-DATE OF PATHOLOGICAL OUTCOME AND SUBJECTIVE DEFINITION OF FAILURE FOR PATIENTS UNDER ACTIVE SURVEILLANCE FOR RECURRENT LOW-RISK NON-MUSCLE INVASIVE BLADDER CANCER: RESULT FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT 40
NEPHRON SPARING SURGERY FOR THE TREATMENT OF SMALL RENAL MASSES: COMPARISON BETWEEN OPEN PARTIAL NEPHRECTOMY, LAPAROSCOPIC PARTIAL NEPHRECTOMY AND LAPAROSCOPIC CRYOABLATION 40
Evaluation of positive surgical margins in patients undergoing robot-assisted and open radical prostatectomy according to preoperative risk groups 40
SENSITIVITY OF [-2]PROPSA (P2PSA) MEASUREMENTS FOR PREDICTION OF BIOCHEMICAL RECURRENCE (BCR) IN MEN AFTER RADICAL PROSTATECTOMY: A 3-YEARS PROSPECTIVE COHORT STUDY 40
THE EUROPEAN NETWORK FOR THE STUDY OF ADRENAL TUMORS STAGING SYSTEM IS PROGNOSTICALLY SUPERIOR TO THE INTERNATIONAL UNION AGAINST CANCER STAGING SYSTEM: A NORTH AMERICAN VALIDATION 40
ASSESSING THE DIAGNOSTIC ACCURACY OF MICRO-ULTRASOUND FOR THE DETECTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: RESULTS FROM A SINGLE-INSTITUTIONAL PRELIMINARY EXPERIENCE 40
Clinical cut-offs of isoform [-2]proPSA (p2PSA) derivatives, namely %p2PSA and PHI (Prostate Health Index) for guiding biopsy decision in Caucasian population 39
Female robotic radical cystectomy. 39
The Surgical Learning Curve for One-stage Anterior Urethroplasty: A Prospective Single-surgeon Study 39
EFFECTIVENESS OF PRE-OPERATIVE PELVIC FLOOR MUSCLE TRAINING FOR POST-PROSTATECTOMY EARLY CONTINENCE RECOVERY 39
Intra-operative frozen section analysis to increase the rate of nerve-sparing procedures without compromising cancer control: Results from a contemporary population of patients treated with robotic assisted radical prostatectomy 39
CLINICAL UTILITY OF PHI (PROSTATE HEALTH INDEX) IN MEN WITH TPSA > 10 NG/ML. RESULTS FROM A MULTICENTRIC EUROPEAN STUDY 39
[The added value of robotic surgery]. 39
Targeted PET/TRUS software fusion‑guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: A feasibility study and preliminary results 39
FIRST CLINICAL PYELOPLASTY SERIES EMPLOYING THE NOVEL DA VINCI SINGLE SITE ROBOTIC PLATFORM FOR THE SURGICAL TREATMENT OF URETERO-PELVIC JUNCTION OBSTRUCTION: FEASIBILITY AND PRELIMINARY RESULTS 38
Totale 4.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.698
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020135 0 0 0 0 0 0 0 0 0 0 0 135
2020/20213.361 12 21 24 16 38 1.074 439 209 772 368 2 386
2021/20221.679 65 38 31 366 17 21 48 253 151 208 425 56
2022/20233.986 721 117 401 402 378 310 16 291 668 380 259 43
2023/20241.666 183 265 446 116 63 201 139 174 39 40 0 0
Totale 10.827